Crossmark

Integrative Structure-Based and AI-Guided Discovery of Natural and Analog UPP1 Inhibitors Targeting the Epigenetic-Metabolic Axis in Lung Adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s12247-026-10654-3

Published Online: 2026-05-14

Published Print: 2026-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De, Arkajit https://orcid.org/0000-0003-0179-4239
License Information

Text and Data Mining valid from 2026-05-14

Version of Record valid from 2026-05-14
More Information

Article History

Received: 7 January 2026

Accepted: 28 March 2026

First Online: 14 May 2026

Declarations

:

: The authors declare no competing interests.This study is fully independent and not related/associated with any research activities of the corresponding author at Van Andel Institute (VAI), Grand Rapids, Michigan, USA.

Document is current

Any future updates will be listed below